The MIT Biotech Group Alumni: Where Are They Now?

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

The Microbiome: New Technology, Commercial Challenges, and Opportunities
It’s Time to Re-Think How We Train and Develop Biomedical Scientists